Evidence map›Paper›PMID 41544104›Full record

ArticlePLoS computational biology2026

Structural analysis of antigenic variation and adaptive evolution of the H5N1 neuraminidase gene.

Muyiwa S Adegbaju, Oluwabuyikunmi Owo-Odusi, Eden T Wirtz, Olanrewaju B Morenikeji, Olusola Ojurongbe, Bolaji N Thomas

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muyiwa S AdegbajuDepartment of Biomedical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.ORCID https://orcid.org/0000-0002-2324-947X
Oluwabuyikunmi Owo-OdusiDepartment of Biomedical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.
Eden T WirtzDepartment of Biology, College of Natural and Health Sciences, Virginia State University, Petersburg, Virginia, United States of America.
Olanrewaju B MorenikejiDepartment of Biology, College of Natural and Health Sciences, Virginia State University, Petersburg, Virginia, United States of America.
Olusola OjurongbeDepartment of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Ogbomosho, Nigeria.
Bolaji N ThomasDepartment of Biomedical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.ORCID https://orcid.org/0000-0002-9758-8116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concern regarding H5N1 outbreak, particularly the accelerated mutagenesis of its core genomic elements, underscores the persistent threat of influenza to global health. Neuraminidase (NA), a pivotal sialidase integral to virion egress and propagation, comprises nine distinct isoforms, exhibiting unique evolutionary trajectories and structural adaptations. Despite extensive characterization of hemagglutinin subtypes, the functional divergence of the nine NA subtypes remains inadequately understood. To address this gap, we conducted a structural analysis of NA subtypes, employing structural superimposition and motif-guided sequence alignment to delineate subtype-specific residues. Hierarchical clustering stratified the nine NA subtypes into four distinct subgroups: NA2 (subgroup I), NA1 and NA4 (subgroup II), NA9/NA7/NA6/NA3 (subgroup III), and NA8/NA5 (subgroup 4). We identified 40 highly conserved and functionally significant amino acid loci, likely modulating enzymatic activity and substrate specificity across subtypes. To investigate the structural basis of adaptation in H5N1, we generated NA1 mutants by swapping family specific position (FSP) residues and analyzed their dynamics using Molecular Dynamics (MD) simulations, complemented by a deep phylogenetic analysis across six host reservoirs. MD simulation parameters reveal a dynamic paradox: the Wild-Type (WT) NA1 maintains a conserved global compactness Rg, which masks a complex, bi-modal switching mechanism essential for its catalytic function, validated by multi-basin free energy landscape (FEL) topography. We identify Lysine-207 (K207) as the master determinant of this switching mechanism and the enzyme's dynamic fate. Substitutions at this conserved nexus produced diametrically opposite outcomes: K207W imposed structural rigidification (abolishing the switch), K207H achieved dynamic preservation, and K207I drove expanded disorder and collapse. Furthermore, dynamic correlation analysis shows that these single-point substitutions function as molecular switches that significantly re-wire the enzyme's allosteric communication networks, extending far beyond the active site. To assess the role of NA1 in host tropism and adaptive evolution, we conducted a phylogenetic analysis of NA1 genes from H5N1 isolates across multiple host reservoirs; H. sapiens, G. gallus, Anser anser domesticus, M. gallopavo, B. taurus, and C. olor. Notably, we observed opposing selection pressures and diversification patterns: G. gallus isolates showed signatures of positive selection consistent with hyper-reassortment, while human isolates displayed highly diverse, sporadic spillover events. We conclude that the evolutionary contribution of NA1 to H5N1 host adaptation is not encoded in static structure, but certain residues such as K207 defines a pivotal mechanism for regulating the enzyme's function through dynamic states. Our MD data thus proposes a novel strategy for next-generation antivirals by targeting this dynamic vulnerability-the Nexus for Dynamic Ablation-to permanently entrain the enzyme in a non-functional conformation.

Indexed as

Antigenic VariationEvolution, MolecularInfluenza A Virus, H5N1 SubtypeNeuraminidaseAmino Acid SequenceAnimalsHumansMolecular Dynamics SimulationPhylogenyProtein ConformationNeuraminidase

Identifiers

PMID41544104
PMCPMC12826504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.